Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Graft Polymer (UK) PLC ( (GB:SVNS) ) is now available.
Solvonis Therapeutics PLC, a company involved in the pharmaceutical industry, has announced a significant change in its voting rights structure. William Potts has reduced his voting rights from 23.17% to 10.33% as of May 27, 2025, indicating a major shift in the company’s shareholder composition. This reduction could impact the company’s governance and decision-making processes, potentially affecting its strategic direction and stakeholder interests.
More about Graft Polymer (UK) PLC
Average Trading Volume: 14,599,829
Technical Sentiment Signal: Sell
Current Market Cap: £7.83M
Learn more about SVNS stock on TipRanks’ Stock Analysis page.